Boston Scientific Corporation (LON:0HOY)
99.02
+1.64 (1.69%)
Jan 7, 2026, 4:53 PM GMT
Boston Scientific Employees
Boston Scientific had 53,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.42% compared to the previous year.
Employees
53,000
Change (1Y)
5,000
Growth (1Y)
10.42%
Revenue / Employee
271.59K GBP
Profits / Employee
39.18K GBP
Market Cap
107.39B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 53,000 | 5,000 | 10.42% |
| Dec 31, 2023 | 48,000 | 3,000 | 6.67% |
| Dec 31, 2022 | 45,000 | 4,000 | 9.76% |
| Dec 31, 2021 | 41,000 | 3,000 | 7.89% |
| Dec 31, 2020 | 38,000 | 2,000 | 5.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,811 |
Boston Scientific News
- 7 days ago - How Is Boston Scientific's Cardiovascular Growth Path Shaping Up? - Nasdaq
- 8 days ago - BSX vs. RMD: Which Medical Device Stock Is the Stronger Play Now? - Nasdaq
- 10 days ago - Boston Scientific: Premium MedTech Growth Story With Attractive Valuation Upside - Seeking Alpha
- 14 days ago - Boston Scientific: Gangbusters Growth, And A Valuation To Match - Seeking Alpha
- 14 days ago - February 2026 Options Now Available For Boston Scientific (BSX) - Nasdaq
- 14 days ago - How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth? - Nasdaq
- 20 days ago - Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 5 Years - Benzinga
- 20 days ago - Decoding Boston Scientific's Options Activity: What's the Big Picture? - Benzinga